Peginterferon alfa-2b and ribavirin for 12 versus 24 weeks in HCV infection [3] (multiple letters)

Brian B. Borg; Jay H. Hoofnagle; Michael J. Henry; Alessandra Mangia; Angelo Andriulli

doi:10.1056/NEJMc052008

Peginterferon alfa-2b and ribavirin for 12 versus 24 weeks in HCV infection [3] (multiple letters)

Brian B. Borg, Jay H. Hoofnagle, Michael J. Henry, Alessandra Mangia, Angelo Andriulli

IRCCS Casa Sollievo della Sofferenza

Research output: Contribution to journal › Article

Original language	English
Pages (from-to)	1182-1183
Number of pages	2
Journal	New England Journal of Medicine
Volume	353
Issue number	11
DOIs	https://doi.org/10.1056/NEJMc052008
Publication status	Published - Sep 15 2005

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1056/NEJMc052008

Cite this

Borg, B. B., Hoofnagle, J. H., Henry, M. J., Mangia, A., & Andriulli, A. (2005). Peginterferon alfa-2b and ribavirin for 12 versus 24 weeks in HCV infection [3] (multiple letters). New England Journal of Medicine, 353(11), 1182-1183. https://doi.org/10.1056/NEJMc052008

@article{0aa0727521b74220980ad7c577f9cff6,

title = "Peginterferon alfa-2b and ribavirin for 12 versus 24 weeks in HCV infection [3] (multiple letters)",

author = "Borg, {Brian B.} and Hoofnagle, {Jay H.} and Henry, {Michael J.} and Alessandra Mangia and Angelo Andriulli",

year = "2005",

month = sep,

day = "15",

doi = "10.1056/NEJMc052008",

language = "English",

volume = "353",

pages = "1182--1183",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "11",

}

TY - JOUR

T1 - Peginterferon alfa-2b and ribavirin for 12 versus 24 weeks in HCV infection [3] (multiple letters)

AU - Borg, Brian B.

AU - Hoofnagle, Jay H.

AU - Henry, Michael J.

AU - Mangia, Alessandra

AU - Andriulli, Angelo

PY - 2005/9/15

Y1 - 2005/9/15

UR - http://www.scopus.com/inward/record.url?scp=24944519999&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24944519999&partnerID=8YFLogxK

U2 - 10.1056/NEJMc052008

DO - 10.1056/NEJMc052008

M3 - Article

C2 - 16167381

AN - SCOPUS:24944519999

VL - 353

SP - 1182

EP - 1183

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 11

ER -